Chimeric antigen receptor T (CAR-T) cells expanded with IL-7/IL-15 mediate superior antitumor effects

被引：97
作者：
Zhou, Jianxia [1 ,2 ]
Jin, Liyuan [1 ,2 ]
Wang, Fuping [1 ,4 ]
Zhang, Yuan [1 ,2 ]
Liu, Bing [3 ]
Zhao, Tongbiao [1 ,2 ]
机构：
[1] Chinese Acad Sci, State Key Lab Reprod Biol, Inst Zool, Beijing 100101, Peoples R China
[2] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China
[3] Acad Mil Med Sci, State Key Lab Prote, Translat Med Ctr Stem Cells, Ivy Translat Med Ctr 307,Lab Oncol,Affiliated Hos, Beijing 100071, Peoples R China
[4] Hebei Univ, Coll Life Sci, Baoding 071002, Peoples R China
来源：
PROTEIN & CELL | 2019年 / 10卷 / 10期
基金：
中国国家自然科学基金; 国家重点研发计划;
关键词：
IMMUNOGLOBULIN; THERAPY; IL-7;
D O I：
10.1007/s13238-019-0643-y
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：764 / 769
页数：6
相关论文
共 50 条
[31]   Chimeric antigen receptor T cells self-neutralizing IL6 storm in patients with hematologic malignancy [J].
Xue, Lei ;
Yi, Yan ;
Xu, Qianwen ;
Wang, Li ;
Yang, Xiaohui ;
Zhang, Yongjing ;
Hua, Xuefei ;
Chai, Xiaoshan ;
Yang, Junjie ;
Chen, Yaxin ;
Tao, Guangshi ;
Hu, Biliang ;
Wang, Xingbing .
CELL DISCOVERY, 2021, 7 (01)
[32]   IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors [J].
Giuffrida, Lauren ;
Sek, Kevin ;
Henderson, Melissa A. ;
House, Imran G. ;
Lai, Junyun ;
Chen, Amanda X. Y. ;
Todd, Kirsten L. ;
Petley, Emma, V ;
Mardiana, Sherly ;
Todorovski, Izabela ;
Gruber, Emily ;
Kelly, Madison J. ;
Solomon, Benjamin J. ;
Vervoort, Stephin J. ;
Johnstone, Ricky W. ;
Parish, Ian A. ;
Neeson, Paul J. ;
Kats, Lev M. ;
Darcy, Phillip K. ;
Beavis, Paul A. .
MOLECULAR THERAPY, 2020, 28 (11) :2379-2393
[33]   Collaboration of chimeric antigen receptor (CAR)-expressing T cells and host T cells for optimal elimination of established ovarian tumors [J].
Spear, Paul ;
Barber, Amorette ;
Sentman, Charles L. .
ONCOIMMUNOLOGY, 2013, 2 (04)
[34]   Chimeric antigen receptor (CAR) modified T Cells in acute myeloid leukemia: limitations and expectations [J].
Guijarro-Albaladejo, Beatriz ;
Marrero-Cepeda, Cristina ;
Rodriguez-Arboli, Eduardo ;
Sierro-Martinez, Belen ;
Perez-Simon, Jose Antonio ;
Garcia-Guerrero, Estefania .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
[35]   Treatment of neuroimmunological diseases with chimeric antigen receptor (CAR) T cells Experience and new developments [J].
Fischbach, Felix ;
Pfeffer, Lena Kristina ;
Heesen, Christoph ;
Friese, Manuel A. .
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2025,
[36]   Antitumor responses in gastric cancer by targeting B7H3 via chimeric antigen receptor T cells [J].
Sun, Fengqiang ;
Yu, Xiaomei ;
Ju, Ruixue ;
Wang, Zhanzhao ;
Wang, Yuhui .
CANCER CELL INTERNATIONAL, 2022, 22 (01)
[37]   IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors in vivo [J].
Koneru, Mythili ;
Purdon, Terence J. ;
Spriggs, David ;
Koneru, Susmith ;
Brentjens, Renier J. .
ONCOIMMUNOLOGY, 2015, 4 (03) :1-11
[38]   Switch receptor T3/28 improves long-term persistence and antitumor efficacy of CAR-T cells [J].
Zhao, Songbo ;
Wang, Chunhua ;
Lu, Ping ;
Lou, Yalin ;
Liu, Huimin ;
Wang, Ting ;
Yang, Shanshan ;
Bao, Ziyou ;
Han, Lin ;
Liang, Xiaohong ;
Ma, Chunhong ;
Gao, Lifen .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (12)
[39]   IL-7+IL-15 are superior to IL-2 for the ex vivo expansion of 4T1 mammary carcinoma-specific T cells with greater efficacy against tumors in vivo [J].
Cha, Esther ;
Graham, Laura ;
Manjili, Masoud H. ;
Bear, Harry D. .
BREAST CANCER RESEARCH AND TREATMENT, 2010, 122 (02) :359-369
[40]   IL-2-inducible T cell kinase deficiency sustains chimeric antigen T cell against tumor cells [J].
Fu, Zheng ;
Huang, Zineng ;
Xu, Hao ;
Liu, Qingbai ;
Li, Jing ;
Song, Keqing ;
Deng, Yating ;
Tao, Yujia ;
Zhang, Huifang ;
Wang, Peilong ;
Li, Heng ;
Sheng, Yue ;
Zhou, Aijun ;
Han, Lianbin ;
Fu, Yan ;
Wang, Chenzhi ;
Choudhary, Saurav Kumar ;
Ye, Kaixiong ;
Veggiani, Gianluca ;
Li, Zhihong ;
August, Avery ;
Huang, Weishan ;
Shan, Qiang ;
Peng, Hongling .
JOURNAL OF CLINICAL INVESTIGATION, 2025, 135 (04)
12345